|
HY-140689-250mg
|
MedChemexpress LLC
|
m-PEG-mal (MW 2000)
|
|
Cancer-programmed cell death
|
|
|
HY-140689-50mg
|
MedChemexpress LLC
|
m-PEG-mal (MW 2000)
|
|
Cancer-programmed cell death
|
|
|
HY-W020780-100mg
|
MedChemexpress LLC
|
mPEG-Mal [CAS 724722-89-8]
|
|
|
|
|
HY-W020780-50mg
|
MedChemexpress LLC
|
mPEG-Mal [CAS 724722-89-8]
|
|
|
|
|
HY-140698-100mg
|
MedChemexpress LLC
|
m-PEG-NHS ester (MW 5000) [CAS 92451-01-9]
|
|
Cancer-programmed cell death
|
|
|
HY-140698-50mg
|
MedChemexpress LLC
|
m-PEG-NHS ester (MW 5000) [CAS 92451-01-9]
|
|
Cancer-programmed cell death
|
|
|
HY-140697-500mg
|
MedChemexpress LLC
|
m-PEG-OH (MW5000) [CAS 9004-74-4]
|
|
Cancer-programmed cell death
|
|
|
HY-140696E-1g
|
MedChemexpress LLC
|
m-PEG-OH (MW 1000) [CAS 9004-74-4]
|
|
|
|
|
HY-140696E-5g
|
MedChemexpress LLC
|
m-PEG-OH (MW 1000) [CAS 9004-74-4]
|
|
|
|
|
HY-140696-1g
|
MedChemexpress LLC
|
m-PEG-OH (MW 2000) [CAS 9004-74-4]
|
|
Cancer-programmed cell death
|
|
|
HY-140696-5g
|
MedChemexpress LLC
|
m-PEG-OH (MW 2000) [CAS 9004-74-4]
|
|
Cancer-programmed cell death
|
|
|
HY-139819-100mg
|
MedChemexpress LLC
|
MPEG-PLA (PEG MW 3000 & PLA MW 50,000)
|
|
|
|
|
HY-139819-250mg
|
MedChemexpress LLC
|
MPEG-PLA (PEG MW 3000 & PLA MW 50,000)
|
|
|
|
|
HY-140704-100mg
|
MedChemexpress LLC
|
m-PEG-triethoxysilane (MW 5000)
|
|
Cancer-programmed cell death
|
|
|
HY-140704-250mg
|
MedChemexpress LLC
|
m-PEG-triethoxysilane (MW 5000)
|
|
Cancer-programmed cell death
|
|
|
HY-140704-50mg
|
MedChemexpress LLC
|
m-PEG-triethoxysilane (MW 5000)
|
|
Cancer-programmed cell death
|
|
|
HY-14609-10mg
|
MedChemexpress LLC
|
MPEP (Hydrochloride) [CAS 219911-35-0]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14609-5mg
|
MedChemexpress LLC
|
MPEP (Hydrochloride) [CAS 219911-35-0]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14609-50mg
|
MedChemexpress LLC
|
MPEP (Hydrochloride) [CAS 219911-35-0]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14609-1mL
|
MedChemexpress LLC
|
MPEP (Hydrochloride) [CAS 219911-35-0] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14609A-250mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-10mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-100mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-5mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-50mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
